Global Digital Pathology Market to Surpass US$ 1,207.8 Million by 2030 - Coherent Market Insights
SEATTLE, Aug. 18, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global digital pathology market is estimated to be valued at US$ 666.0 million in 2022 and is expected to exhibit a CAGR of 7.7% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Digital Pathology Market:
Integration of cloud computing with digital pathology is also expected to boost growth of the market over the forecast period. Use of cloud computing in digital pathology can help to deliver cost effective healthcare and also help to manage the growing amount of data that is generated by the technology.
Major hospitals are adopting digital pathology for diagnosis of cancer. For instance, in June 2019, Seoul St. Mary's Hospital, a part of Catholic Medical Center (CMC), started operating a digital pathology system that aids in the diagnosis of cancer.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/379
Key Market Takeaways:
The global digital pathology market is expected to exhibit a CAGR of 7.7% during the forecast period due to the Key players in the market are focused on raising funds to expand their product portfolio. For instance, in December 2019, Paige, a U.S.-based company engaged in computational pathology, announced closure of Series B funding round of US$ 45 million.
Among Application, Histopathology segment is expected to dominate the segment growth over the forecast period, owing to the increasing prevalence of the cancer is expected to support growth of the segment over the forecast period. For instance, according to National Cancer Institute (NCI), an estimated 1,735,350 new cases of cancer were diagnosed in the U.S. in 2018. Estimated numbers of new cancer cases and deaths in 2022 (in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S.)
The hospitals sub-segment in end user segment accounted for US$ 113.0 Mn in the global digital pathology market in 2022. Increasig prevalence of various diseases such as cancer, infectious diseases and others is expected to increase the demand for efficient, fast, and accurate diagnosis.
Key players operating in the global digital pathology market include Perkin Elmer, Inc., Definiens AG, Sectra ABss, Koninklijke Philips N.V., Paige, GE Healthcare, Inspirata Co.,Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd., and Hamamatsu Photonics, K.K.
Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/379
Global Digital Pathology Market, By Offering:
Global Digital Pathology Market, By Application:
Global Digital Pathology Market, By End User:
Global Digital Pathology Market, By Region:
Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/379
Find related trending report below:
Anatomic Pathology Market, by Product Type (Instrument and Consumables), by Application (Disease Diagnosis, Drug Discovery & Development, and Others), by End User (Pathology Labs, Research Institutes, Hospitals, and Others), and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.